title: Tamoxifen, balancing risks and benefits.
authors.affiliation: Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: L
authors.initials: L
authors.lastname: Bergman
authors.forename: J
authors.initials: J
authors.lastname: Benraadt
authors.forename: F E
authors.initials: FE
authors.lastname: van Leeuwen
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000453:epidemiology*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012306:Risk; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen